Menopause Articles & Analysis
16 news found
Health and wellbeing has been embedded into various policies including volunteering, home-working, neurodiversity, menopause and the Diversity, Equity, Inclusion and Belonging policy.The Wellbeing at Work programme aims to encourage companies to promote positive behaviours and easily accessible information relating to wellbeing and mental health, seeking to enable the East Sussex ...
Blockbuster potential is also attributed to elinzanetant, an innovative, non-hormonal small molecule being developed for the treatment of vasomotor symptoms during menopause. Vasomotor symptoms or hot flashes are reported by up to 80 percent of women at some point during the menopausal transition. ...
ByBayer AG
Hormonal changes among women, especially post-menopausal women, are essential leading factors to this disease. Estrogen is produced by the female body to protect bones. However, its production decreases drastically after the onset of menopause, thus making bones susceptible to greater damage. Even for the women who are not post-menopausal, if ...
Osteoporosis is a disorder that causes the bone density to reduce with time, making bones so weak they get fractured even with a light fall. Regular testing has many benefits as it is tracked by HEDIS (Healthcare Effectiveness Data and Information) to ensure early detection among women to manage their condition properly. Read on to know ...
Vasomotor symptoms caused by endocrine therapy impact quality of life and treatment adherence and cannot currently be addressed as no treatment options are available. About Menopause By 2030, the world population of menopausal and postmenopausal women is projected to increase to 1.2 billion, with 47 million new entrants each year. Menopause is ...
ByBayer AG
Bayer offers a wide range of effective short- and long-acting birth control methods as well as therapies for menopause management and gynecological diseases. Bayer is also focusing on innovative options to address the unmet medical needs of women worldwide. Today, Bayer’s research and development efforts focus on finding new treatment options for menopause ...
ByBayer AG
Additionally, the poster had previously been presented at the North American Menopause Annual Meeting in Washington, D.C. in December 2021 and at the International Society for the Study of Women’s Sexual Health Annual Meeting in Dallas, Texas in March 2022. ...
In the trial, researchers investigated whether they could prolong the time cancer was controlled in post-menopausal women whose cancer had gotten worse by adding capivasertib to existing fulvestrant therapy. ...
Randomised patients were stratified based on their Recurrence Score result, menopausal status and type of lymph node surgery. Further analyses and additional patient follow up are planned by the SWOG investigators. ...
CMD can occur in both sexes, but is more prevalent in women, especially after menopause. Estimates from the Women’s Ischemia Syndrome Evaluation (WISE) study show that there are at least three to four million Americans with ischemia despite the absence of obstructive atherosclerosis, with associated poor quality of life, psychological distress, and health-care costs that ...
Randomised patients were stratified based on their Recurrence Score result, menopausal status, and the type of lymph node surgery. The use of the Oncotype DX test in early-stage breast cancer is supported by prospective outcomes from more than 17,000 patients with node-positive disease and more than 83,000 patients with node-negative disease, including the TAILORx study. ...
NEW YORK, Dec. 8, 2015 /PRNewswire/ — S1 Biopharma, Inc. a leading developer of first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men, and CKD Pharmaceuticals, a leading pharmaceutical company in South Korea, today announced that they have entered into a commercialization agreement for Lorexys™, S1 ...
“We already know that the major known risk factor in breast cancer is exposure to estrogen, so girls who enter puberty earlier and women who enter menopause later have higher risk,” she says. Vandenberg’s investigation will focus on an estrogen-mimicking chemical called bisphenol S (BPS), related to bisphenol A (BPA) and now often used in plastics, thermal ...
Amerifit products are sold in most major mass, club, drug, grocery and specialty stores and include: Culturelle®, a leading probiotic supplement; AZO, the leading OTC brand addressing symptom relief and detection of urinary tract infections; and Estroven®, the leading all-natural nutritional supplement brand addressing the symptoms of menopause. For more information on Martek ...
Amerifit products are sold in most major mass, club, drug, grocery and specialty stores and include: Culturelle®, a leading probiotic supplement; AZO, the leading OTC brand addressing symptom relief and detection of urinary tract infections; and Estroven®, the leading all-natural nutritional supplement brand addressing the symptoms of menopause. For more information on Martek ...
Factors such as a woman's genetic disposition, her age when she has children, or the menopause play an important part in the development of breast cancer. However, laboratory and epidemiological evidence suggests that man-made chemicals which mimic the hormone oestrogen also contribute to breast cancer. ...